Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly Acute Myeloid Leukemia (AML) and Advanced Myelodysplastic Syndrome (MDS)

NCT02121418 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT02121418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02121418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly Acute Myeloid Leukemia (AML) and Advanced Myelodysplastic Syndrome (MDS)
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2014
Completion date
February 14, 2018
Enrollment
12 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myelomonocytic leukemia-2, myelodysplastic syndrome, myeloproliferative neoplasm, untreated adult acute myeloid leukemia